At the initial completion of this deal, expected to take place within the next few months, FDBU will buy 49% of the total membership stakes in Kalon and will be allowed to appoint most of Kalon's board members.
Subsequently, FDBU may raise its interest share up to 100% subject to achievement of certain milestones set forth in the Interest Purchase Agreement.
27 October 2014 - Japan's Fujifilm Holdings Corp (TYO:4901) said today its unit Fujifilm Diosynth Biotechnologies USA Inc (FDBU) had agreed to acquire US biopharmaceutical contract manufacturing organisation (CMO) Kalon Biotherapeutics LLC for an undisclosed price.
FDBU will acquire Kalon from the company's current owners, the State of Texas and the Texas A&M University System (TAMUS), the buyer further explained.
, a FUJIFILM subsidiary on October 22, 2014, inked an Interest Purchase Agreement, with the possessor of Kalon: the State of Texas, acting by and through the Office of the Governor, and The Texas A&M University System or TAMUS.